Search

Your search keyword '"Castellà, Maria"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Castellà, Maria" Remove constraint Author: "Castellà, Maria" Database Unpaywall Remove constraint Database: Unpaywall
12 results on '"Castellà, Maria"'

Search Results

1. What will (and should) be improved in CAR immunotherapy?

2. The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma

3. Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

4. Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

5. Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

6. Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

7. Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

8. CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

11. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

12. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability

Catalog

Books, media, physical & digital resources